Fingerprint Dive into the research topics where Sister Institutions is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Genes Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Steinar Aamdal

Steinar Aamdal

Person: Academic

19842019
No photo of Salah Abbasi
20062017
No photo of Hikmat Abdel-Razeq
19972019

Research Output 1906 2019

10q23.31 microduplication encompassing PTEN decreases mTOR signalling activity and is associated with autosomal dominant primary microcephaly

Oliveira, D., Leal, G. F., Sertié, A. L., Caires, L. C., Goulart, E., Musso, C. M., De Oliveira, J. R. M., Krepischi, A. C. V., Vianna-Morgante, A. M. & Zatz, M., Aug 1 2019, In : Journal of medical genetics. 56, 8, p. 543-547 5 p.

Research output: Contribution to journalArticle

Sirolimus
Microcephaly
Fibroblasts
PTEN Phosphohydrolase
Megalencephaly
2 Citations (Scopus)

10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma

Chen, L., Zhang, Y., Lai, S. Z., Li, W. F., Hu, W. H., Sun, R., Liu, L. Z., Zhang, F., Peng, H., Du, X. J., Lin, A. H., Sun, Y. & Ma, J., Jan 1 2019, In : Oncologist. 24, 1, p. e38-e45

Research output: Contribution to journalReview article

Intensity-Modulated Radiotherapy
Radiotherapy
Confidence Intervals
Survival
Therapeutics

18F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications

Ye, S., Liu, S., Xiang, L., Wu, X. & Yang, H., Mar 13 2019, In : BMC cancer. 19, 1, 226.

Research output: Contribution to journalArticle

Open Access
Fluorodeoxyglucose F18
Carcinoma
Recurrence
Platinum
Tumor Burden